News Lonza Group AG

Stocks

LONN

CH0013841017

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 07:46:44 21/07/2026 pm IST			5-day change	1st Jan Change
564.80 ^CHF	-0.04%		-3.47%	+4.54%

20/07	Zonebourse corporate earnings calendar: week of July 20 to 24, 2026
15/07	Lonza Reaffirmed at Outperform as RBC Notes Tight Supply, Demand in Biologics	MT

All News

Mentions Relevance

15/07	Lonza Reaffirmed at Outperform as RBC Notes Tight Supply, Demand in Biologics	MT
02/07	Nona Biosciences And Lonza Enter Strategic Collaboration To Develop Best-In-Class Single-Domain Antibody-Based BBB-Crossing Technology For CNS Diseases	CI
01/07	Lonza Group AG Expands Strategic Collaboration With Leading US Biopharmaceutical Company	CI
01/07	Lonza Adds Biologics Programs to US Biopharma Partnership	MT
01/07	Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company	EQ
30/06	Lonza Plans Expansion of Payload-linker Manufacturing Capacity in Switzerland	MT
30/06	Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing	EQ
30/06	Lonza Group AG Expands HPAPI Capacity In Visp To Support Payload-Linker Manufacturing	CI
23/06	Lonza Publishes Restated Half-Year 2025 Financials Reflecting Capsules & Health Ingredients as Discontinued Operations	EQ
23/06	Lonza Group Reportedly Explores Sale of Capsules and Health Ingredients Division	CI
22/06	Iconovo, Lonza Finalize Long-term Strategic Collaboration	MT
18/06	Swiss trade surplus at CHF 6.11 bln in May	RE
16/06	Lonza Issues Exclusive, Target-Specific License to Antharis Therapeutics to Advance Next-Generation Dual Payload ADCs for Gastrointestinal Cancers	CI
10/06	AlphaValue/Baader Europe Cuts EPS Forecasts for Lonza Group on Division Sale	MT
09/06	LONZA GROUP LTD Announces Management Changes	CI
09/06	Lonza Group: Incorporating Capsules & Health Ingredients divestment
09/06	Lonza Appoints Hans Trees as Global Head of Communications	EQ
04/06	Stipple Bio, Inc. And Lonza Group Ltd Enter Multi-Target License Agreement To Advance Precision Oncology ADC Therapies	CI
04/06	Intron Health Downgrades Lonza Group to Sell, Cuts PT	MT
11/05	Morningstar Upgrades Lonza Group to Buy	MT
08/05	Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved	EQ
08/05	Lonza Group AG Announces Board and Remuneration Committee Appointments	CI
08/05	Lonza Group AG Approves Dividend, Payable from May 15, 2026	CI
08/05	Lonza Group AG, Q1 2026 Earnings Call, May 08, 2026
08/05	Lonza Shares Little Changed After Quarterly Update